PredicineCARE™ Liquid Biopsy Assay Featured in NEJM as Pivotal Tool in Roche’s Phase III Itovebi Breast Cancer Trial
PredicineCARE™ was utilized to identify and enroll
The post PredicineCARE™ Liquid Biopsy Assay Featured in NEJM as Pivotal Tool in Roche’s Phase III Itovebi Breast Cancer Trial appeared first on ForexTV.